Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society
2022 · Breast Cancer Research · 160 citations
https://doi.org/10.1186/s13058-022-01519-x
J
Juneyoung Ahn
The Catholic University of Korea Uijeongbu St. Mary's Hospital(KR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
305
Citations
5
h-index
5
i10-index
Juneyoung Ahn is an academic researcher from The Catholic University of Korea Uijeongbu St. Mary's Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Breast Lesions and Carcinomas. The author has an h-index of 5, co-authored 12 publications.
ORCID: 0000-0002-6840-4496Papers by this author
worksAxillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis
2020 · Breast Cancer Research and Treatment · 25 citations
https://doi.org/10.1007/s10549-020-05636-z
Additional file 3 of Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19388903
Additional file 2 of Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19388900
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat